share_log

Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.

Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.

Adaptimmune治療公司股價上漲，此前該公司公佈了好於預期的第二季度每股收益業績，並重申了指導意見。
Benzinga ·  2022/08/05 02:55

Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.

Adaptimmune治療公司股價上漲，此前該公司公佈了好於預期的第二季度每股收益業績，並重申了指導意見。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論